Management of old world cutaneous leishmaniasis in refugee children

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages 357-359

  Crogan, Joanne ^a,b   Gunasekera, Hasantha ^a,b   Wood, Nicholas ^a,b   Sheikh, Mohamud ^a   Isaacs, David ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amphotericin; Children; Fluconazole; Refugee; Toxicity

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CREATININE; FLUCLOXACILLIN; FLUCONAZOLE; MAGNESIUM; TOOTHPASTE;

ACUTE KIDNEY FAILURE; ANOREXIA; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG FEVER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESTHETICS; FEMALE; HUMAN; HYPERPHOSPHATEMIA; HYPOMAGNESEMIA; KIDNEY DISEASE; MALE; MEDICAL RECORD REVIEW; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REFUGEE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SECONDARY INFECTION; SIDE EFFECT; SKIN LEISHMANIASIS; TOPICAL TREATMENT;

EID: 77950291432     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181c2a1fd     Document Type: Article

References (10)

1. González U, Pinart M, Rengifo-Pardo M, et al. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev. 2009:CD004834.
2. González U, Pinart M, Reveiz L, et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev. 2008:CD005067.
3. Murray H, Berman J, Davies C, et al. Advances in Leishmaniasis. Lancet. 2005;366:1561-1577.
4. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med. 2003;49:50-54.
5. Reithinger R, Mohsen M, Wahid M, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis. 2005;40:1148-1154.
6. Asilian A, Jalayer T, Nilforooshzadeh M, et al. Treatment of Cutaneous Leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomised trial in the Islamic Republic of Iran. Bull World Health Organ. 2003;81:353-359.
7. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paramomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006;31:634-637.
8. Alrajhi A, Ibrahim E, DeVol E, et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by leishmania major. N Engl J Med. 2002;346:891-895.
9. Nassiri-Kashani M, Firooz A, Khamesipour A, et al. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous laishmaniasis. J Eur Acad Dermatol Venereo. 2005;19: 80-83.
10. Zvulunov A, Cagnano E, Frankenburg S, et al. Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B. Pediatr Infect Dis J. 2003;22:567-569.